Publication date: 15 March 2027 Source: Clinica Chimica Acta, Volume 594 Author(s): Hiba Adnan Aziz Abu Omaima, Saba Salih Saihood, Abbas Hasan Burhan, Wiqar Adnan Azeez Aboomaima, Mehdi Rostami, Ramin Raoufinia, Ali Mahmoudi
Precision medicine in MASLD: Integrating genetics, multi-omics, and artificial intelligence for risk stratification and targeted therapy. // Clinica Chimica Acta. – URL: https://www.sciencedirect.com/science/article/pii/S0009898126020747?dgcid=rss_sd_all
Precision medicine in MASLD: Integrating genetics, multi-omics, and artificial intelligence for risk stratification and targeted therapy. Clinica Chimica Acta. https://www.sciencedirect.com/science/article/pii/S0009898126020747?dgcid=rss_sd_all
“Precision medicine in MASLD: Integrating genetics, multi-omics, and artificial intelligence for risk stratification and targeted therapy.” Clinica Chimica Acta.
@article{article93502,
title = {Precision medicine in MASLD: Integrating genetics, multi-omics, and artificial intelligence for risk stratification and targeted therapy},
journal = {Clinica Chimica Acta},
url = {https://www.sciencedirect.com/science/article/pii/S0009898126020747?dgcid=rss_sd_all}
}
ABSTRACT Three‐dimensional (3D) printing enables precise control over scaffold geometry, porosity, material distribution, and spatial delivery of cells and bioactive cues. However, features intended to improve biological fidelity often...